| (210) | Number of the EPO application | 19708817 |
| (220) | Filing date of the EPO application | 2019.02.28 |
| (80) | EPO patent specification publication (B) | EPB nr. 18/2022, 2022.05.04 |
| (110) | EPO patent number | 3759083 |
| (11) | Number of the document | MD 3759083 T2 |
| (21) | Number of the application | e 2021 0025 |
| (71) | Name(s) of applicant(s), code of the country | Janssen Sciences Ireland Unlimited Company, IE; |
| (72) | Name(s) of inventor(s), code of the country | MC GOWAN David Craig, BE;
EMBRECHTS Werner Constant Johan, BE;
GUILLEMONT Jérôme Émile Georges, FR;
COOYMANS Ludwig Paul, BE;
JONCKERS Tim Hugo Maria, BE;
RABOISSON Pierre Jean-Marie Bernard, BE; |
| (73) | Name(s) of owner(s), code of the country | Janssen Sciences Ireland Unlimited Company, IE; |
| (54) | Title of the invention | 2,4-diaminoquinazoline derivatives and use thereof in the treatment of virus infections, cancer or allergies |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07D 239/95 (2006.01.01); A61K 31/517 (2006.01.01); A61P 1/16 (2006.01.01); A61P 37/06 (2006.01.01); A61P 35/00 (2006.01.01); A61P 31/12 (2006.01.01) |
| (19) | Country | IE |
| (41) | Date of publication of the application | 2021.01.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2022.09.30 |
| (30) | Priority | 18159583, 2018.03.01, EP |
| (74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |
| (86) | International application | PCT/EP2019/054941, 2019.02.28 |
| (87) | International publication | WO 2019/166532, 2019.09.06 |